Login:
Share:
Email Facebook Twitter

Add Gw Pharmaceuticals to quick picks

Gw Pharmaceuticals Share Price (GWP)



Share Price Information for Gw Pharmaceuticals (GWP)


Share Price: 224.50Bid: 223.00Ask: 225.00Change: 0.00 (0.00%)No Movement on Gw Pharm.
Spread: 2.00Spread as %: 0.90%Open: 218.75High: 224.50Low: 214.75Yesterday’s Close: 224.50

Gw Pharmaceuticals Plc Ord 0.1P

Gw Pharmaceuticals is listed in the FTSE AIM 100, FTSE AIM UK 50, FTSE AIM All-Share
Gw Pharmaceuticals is part of the Pharmaceuticals & Biotechnology sector




Intraday Gw Pharmaceuticals Share Chart


Intraday Gw Pharmaceuticals Share Price Chart


Share Price SpacerPrice
224.50

Share Price SpacerBid
223.00

Share Price SpacerAsk
225.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
0

Share Price SpacerOpen
218.75

Share Price SpacerHigh
224.50

Share Price SpacerLow
214.75

Share Price SpacerClose
224.50

Share Price SpacerCurrency
GBX

3 Month Gw Pharmaceuticals Share Graph


3 Month Gw Pharmaceuticals Share Price Graph


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 214.99m £482.64m 3,000

52 Week High 422.00 52 Week High Date 11-MAR-2014
52 Week Low 45.25 52 Week Low Date 13-JUN-2013

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -74.833 -3.00 0.00 0.00


London South East Users info for Gw Pharmaceuticals


Users who watch GWP also watch: Victoria Oil, Marks & Sp.

Users who hold GWP also hold: Hsbc Hldgs.uk, Royal Bank Scot, Lloyds Grp., Rockhopper, National Grid


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

17-Apr-14
15:56:43
223.00
10,000
Sell* 
223.00
225.00
22.30k
Trade Type:
Ordinary

17-Apr-14
16:40:10
219.86
1,200
Sell* 
223.00
225.00
2,638
Trade Type:
Ordinary
Bargain conditions apply

17-Apr-14
16:35:28
224.50
9,063
Buy* 
222.75
224.50
20.35k
UT 
Trade Type:
Uncrossing Trade


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Gw Pharmaceuticals trades >>

Directors Deals for Gw Pharmaceuticals (GWP)
Trade DateActionNotifierPriceCurrencyAmountHolding
26-Nov-13Transfer To
Trade Notifier Information for GW Pharmaceuticals
Justin Gover held the position of Managing Director at GW Pharmaceuticals at the time of this trade.
 Justin Gover
0500,0003483368
30-Sep-13Notification of Holding
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
000
10-Jun-13Buy
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
0.1GBX7,50012500
View more Gw Pharmaceuticals directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Thu 19:41
tfish
RE: Comparing GWP product to Cannab..
224.50
No Opinion

Investors also, even 'more so' BUY into a share because of a nonbusiness related attraction. A buzz or a some kind of hype/selling. This is actually proven by psychology. Anyway... If you feel GWP has not been dented one little bit by legalisation, good for you.
Thu 12:57
thewonderbrabar
RE: Comparing GWP product to Cannab..
219.25
No Opinion

No but investors will buy shares in the company based on what they think its potential and health is. To do that you need to appreciate who the customers/users are and why they use it. I think the people who use GWs products for 'highs' is negligible if even existent, I don't know if it's even possible. The success their products have had treating suffering patients has been proven, replacing loads of pills with a natural product is better. And then replacing a natural product with scienficitcally optimised and refined natural product is even better.
Thu 10:57
tfish
RE: Comparing GWP product to Cannab..
216.50
No Opinion

No not 'all users' at all. Just some. And as mentioned before Share Price isn't linked to any 'users' its linked to Private Investors
Thu 09:07
thewonderbrabar
RE: Comparing GWP product to Cannab..
218.25
No Opinion

Guess my view is comical. But it's comical to suggest that GW users use their products purely because they can't use actual cannibas. The share price hit a peak because of all the legalisation news and exposure. No more new now and the tech sell off USA. But I strongly suspect that when legalisation of weed makes it into the papers again we will see an increase in sp. GW is/was widely regarded as the best weed stock and that's not changed for investors who will be reminded. Price will level off around 200 or continue to creep down until their is more news.
Wed 16:56
tfish
RE: Comparing GWP product to Cannab..
219.25
No Opinion

Unfortunately the share price isn't effected solely by GWPs product & its abilities. The reality is the share price is sold on the mystic & appeal of harnessing an illegal super drug, for many GWP product users this would be their only access to it legally. That is no longer the case for many. GWPs appeal wains on legalisation. To deny this is comical.
Wed 11:35
kingskin
RE: Comparing GWP product to Cannab..
219.00
No Opinion

at last someone with some sense!, i was going to post the same thing about aspirin...... this share is set to take off, but it wont be for a couple of years yet, it is currently overpriced and could go as low as £1 this year. its the next few years that will be interesting now the canna hype has died down, and its the next 5 years that will really see this share hit the highs. i doubt it will hit the 4.80 mark again for quite a while.

Share prices shown are taken at time of message posting.
NEWThread ViewThread View
View more share chat for Gw Pharmaceuticals (GWP) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Gw Pharmaceuticals Plc Ord 0.1P home pageWebsite: Gw Pharmaceuticals Plc Ord 0.1P
Website Description: GW Pharmaceutical



Sign up for Live Prices


CD02WL.001.081313


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.